Chris Delvecchio

Background

About Chris Delvecchio

Dr. Chris Delvecchio is driven by a passion to solve complex challenges and affect positive change across the health research and innovation ecosystem. Working with leading multinational companies, investor groups and healthcare and academic organizations globally, Chris has led multifaceted initiatives that have produced measurable impact for his clients. Chris has deep experience in developing original strategies and business plans that help organizations assume or retain a position of leadership, conducting in-depth opportunity evaluations that underpin bankable investment decisions, devising biopharmaceutical product strategies that position programs for health impact and commercial success and creating access and policy strategies that prepare markets for innovation. His work has informed hundreds of flagship programs with multi-billion dollar potential and helped public and private organizations across North America, Europe, Asia and the Middle East define their competitive niche, unlock new sources of revenue and advance innovation in order to realize the full health and socioeconomic potential of their work. In addition to his work with Shift Health, Chris participates on a Strategic Advisory Board for a new start-up in the vaccines arena and volunteers his time with new entrepreneurs seeking to translate their ideas into thriving businesses. Previously, Chris volunteered with Life Sciences Ontario's Knowledge and Networking Committee. He also served as a Project Manager for an early-stage drug discovery company developing the world’s first high-throughput live animal screening system to test new drugs. Chris graduated with a PhD in Biochemistry and Biomedical Sciences from McMaster University where he specialized in endocrinology and nuclear hormone receptors. He has presented his research at several international scientific conferences and has published his work in top-tier journals.